Norway· NO-ID_BAC179AD-42B3-4731-A2A4-4D6CC53863FB
Dexdor
A dexmedetomidine product containing dexmedetomidine, registered in Norway by Orion Corporation - Espoo. The same ATC class is registered in 17 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dexmedetomidine is registered in 17 of 19 countries.
Countries holding a registration under ATC N05CM18 (dexmedetomidine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Dexmedetomidine · ATC N05CM18
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Dexmedetomidine
- Manufacturer
- Orion Corporation - Espoo
- Country
- Norway (NO)
- ATC code
- N05CM18
- ATC class
- Dexmedetomidine
- Defined daily dose
- 1 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 9
4 priced- no_varenummer4703974 x 4NOK 2052
- no_merkevare_idID_BAC179AD-42B3-4731-A2A4-4D6CC53863FB
- no_varenummer39069925 x 2NOK 6335.5
- no_varenummer5968815 x 2NOK 1296.1
- no_varenummer0344944 x 10NOK 5075.7
- gtin6432100048035
- gtin6432100048011
- gtin6432100048004
- gtin6432100048028
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
79 interactions on record for dexmedetomidine.
Graded by severity as the source publishes them — 60 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexmedetomidine · interactions on record
79 records
- 60 moderate
- 19 info
Most severe, free to view
- PapaverineA03AD01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexmedetomidine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDEXDOROrion Corporation, Espoo
- BelgiumDexmedetomidine Accord 100 µg/mlAccord Healthcare
- SwedenDexdor 100 mikrogram/ml Koncentrat till infusionsvätska, lösningOrion Corporation
- SwitzerlandDexdor 1000ug/10ml, Konzentrat zur Herstellung einer InfusionslösungOrion Pharma AG
- United StatesDexmedetomidineWG Critical Care, LLC
- FinlandDexdorOrion Corporation
- IrelandDexdor 100 micrograms/ml concentrate for solution for infusionOrion Corporation
- PolandDexdorOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dexmedetomidin Altan, Dexmedetomidin Altan Pharmaceuticals, S.A.
- Belgium · Dexmedetomidine A.Forall, Dexmedetomidine Baxter
- Bulgaria · Dexmedetomidine Ever Valinject, Dexmedetomidine Kalceks
- Cyprus · Dexmedetomidine Baxter, Dexmedetomidine Ever Valinject
- Czechia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma
- Germany · Dexmedetomidin B. Braun, Dexmedetomidin Baxter
- Denmark · Dexmedetomidin Kalceks, Dexmedetomidin Viatris
- Estonia · Dexmedetomidine Auxilia, Dexmedetomidine Kabi
- Spain · Dexmedetomidina Altan, Dexmedetomidina B. Braun
- Finland · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
- France · Dexmedetomidine Altan, Dexmedetomidine Ever Pharma
- United Kingdom (Northern Ireland) · Dexmedetomidine 100 Micrograms/Ml Concentrate For Solution For Infusion, Dexmedetomidine Altan Pharma
- Greece · Dexmedetomidine /Kabi, Dexmedetomidine Ariti
- Croatia · Deksmedetomidin Kabi, Deksmedetomidin Kalceks
- Hungary · Dexmedetomidin Ever Pharma, Dexmedetomidine Kabi
- Ireland · Dexmedetomidine As Kalceks, Dexmedetomidine B. Braun
- Iceland · Dexdor, Dexmedetomidine Rph Pharma
- Italy · Dexmedetomidina Galenica Senese, Dexmedetomidina Hikma
- Liechtenstein · Dexdor
- Lithuania · Dexmedetomidine Kabi, Dexmedetomidine Kalceks
- Luxembourg · Dexmedetomidine Baxter, Dexmedetomidine Kabi
- Latvia · Dexmedetomidine Kalceks, Dexmedetomidine Pharmidea
- Malta · Dexmedetomidine Ever Valinject
- Netherlands · Dexmedetomidine Altan Pharmaceuticals, S.A., Dexmedetomidine B. Braun
- Poland · Dexmedetomidine Ever Pharma, Dexmedetomidine Farmak
- Portugal · Dexmedetomidina A.Forall, Dexmedetomidina Acure
- Romania · Dexmedetomidină Kabi, Dexmedetomidină Kalceks
- Sweden · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
- Slovenia · Deksmedetomidin Kalceks, Deksmedetomidin Viatris
- Slovakia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47c10497-40ad-4ad4-ab37-3055ff270ea0 GET /v1/drugs/47c10497-40ad-4ad4-ab37-3055ff270ea0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Deksmedetomidin",
"merkevare_id": "ID_BAC179AD-42B3-4731-A2A4-4D6CC53863FB",
"name_form_strength": "Dexdor kons til inf oppl 100 mikrog/ml",
"prescription_group": "C"
}See everything about dexmedetomidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.